Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the company’s headquarters in Hanau, Germany. Heraeus, a business line of Heraeus Precious Metals, is the leading global market supplier for Platinum-based HPAPIs, which are a key component used in chemotherapy drugs.
Work started on the new production line in accordance with the latest EHS and GMP requirements in 2018, representing a multi-million Euro investment for Heraeus in response to the sustained global increase in demand for its products.
Successful validation of its new production line means that Heraeus has now significantly increased its manufacturing capacity to help in the fight against cancer.
“We are proud to have brought this project to a successful conclusion in such a short space of time. Our customers can now benefit from our additional capacity and quicker delivery times for top-quality active ingredients,” said Marcus Hannakam, Head of Pharmaceutical Ingredients at Heraeus.
“The global increase in demand for our active ingredients and the concentration on experienced, reliable manufacturers were key for our investment. This represents a major step toward long-term success, both for our customers and for Heraeus Pharmaceutical Ingredients.
“The expansion further secures the market leadership of Heraeus Pharmaceuticals Ingredients. As a long-established partner in the battle against cancer, the business line already enjoys an excellent reputation among customers and regulatory authorities which we intend to strengthen further with this latest investment.”
Pt hAPIs are important resources in treating cancer, especially in combination therapies, and are used to combat diseases such as lung cancer, colorectal cancer, ovarian cancer, and testicular cancer.
The demand for Pt hAPIs in cancer treatment is rising for various reasons: demographic change is resulting in more and more cancer patients, while access to chemotherapies in emerging economies is improving. As a result, the current market availability of these vital ingredients is reaching its limits, which affects not only the pharmaceutical industry, but the entire healthcare system as well.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!